76TiP RMC-4630 and sotorasib for advanced KRASG12C NSCLC after failure of prior standard therapies: A phase II trialM.L. Johnson, R. Langdon, D. Ellison, A. Spira, H. Amin, M. Castine,D.B. Daniel, S. Sohoni, Y-C. Chen, J. Hayes, Y. Mu, S. Masciari,X. Wang, S. ToyaAnnals of Oncology（2022）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
